There is a trend towards using the axillary artery cannulation (AXC) site for cardiopulmonary bypass surgery in patients requiring acute type A aortic dissection (AAD) repair. However, AXC has not been established as a routine procedure, because there is controversy about its clinical advantage when compared with femoral artery cannulation (FAC). This meta-analysis assesses major short-term outcomes in patients undergoing acute AAD repair with AXC or FAC using non-randomized retrospective studies dating from 1992 to 2011 comparing AXC and FAC for major outcomes. Outcomes of interest were short-term mortality, neurological dysfunction and malperfusion. The fixedeffects model was used. Sensitivity and heterogeneity were analysed. Analysis of nine non-randomized studies comprising 715 patients [AXC, 359 (50.2%) and FAC, 356 (49.8%)] showed a significantly lower incidence of short-term mortality in the AXC group [odds ratio, 0.25, 95% confidence interval (CI) (0.15, 0.42), χ 2 = 7.23, P < 0.01]. The pattern of incidence of neurological dysfunction among the AXC group [odds ratio, 0.46, 95% CI (0.29, 0.72), χ 2 = 9.01, P < 0.01] was similar. The incidence of malperfusion did not differ [odds ratio, 0.84, 95% CI (0.37, 1.90), χ 2 = 2.25, P = 0.67]. Because no study was a randomized trial, our results are more uncertain than indicated by the 95% CI. Nevertheless, AXC seems to give better short-term mortality and neurological dysfunction rates than FAC.
INTRODUCTION
For a long time, the femoral artery (FA) has been used as an arterial cannulation site for cardiopulmonary bypass (CPB) surgery when the ascending aortic cannulation was deemed unfeasible, such as with type A aortic dissection (AAD), and a low complication rate was reported [1, 2] . In the late 1990s, the axillary artery was described as an alternative cannulation site for an arterial cannulation in patients requiring AAD surgery [3] [4] [5] [6] , because it facilitates antegrade cerebral perfusion (ACP) [4, [7] [8] [9] . However, whether the axillary artery should be used routinely in acute AAD repair is controversial. In this meta-analysis, we present our analysis of investigations dealing with femoral or axillary cannulation in acute AAD repair.
MATERIALS AND METHODS
Literature search and selection of articles MEDLINE, EMBASE and Cochrane Library CENTRAL were searched up to the date of 1 November 2013. The key words used were: axillary artery OR subclavian artery AND femoral artery AND aortic diseases. The articles were also identified by using the function 'related articles' in PubMed. All the abstracts, studies and citations scanned were reviewed. Of 824 studies, 9 were selected. All titles and abstracts were read by two independent investigators (Zongli Ren and Zhiwei Wang). Articles were included if studies: (i) involved cannulation of the axillary/subclavian artery and femoral cannulation in patients with acute AAD repair; (ii) provided baseline characteristics of the recruited patients (in each study must be present); (iii) stated the incidence of at least one of the basic outcome criteria; (iv) reported on a series of at least 10 patients to prevent bias arising from small sample populations. Exclusion criteria were as follows: (i) case reports, and case series with less than 10 patients; (ii) no original data reported; (iii) studies in which the cannulation technique [whether axillary artery cannulation (AXC) or femoral artery cannulation (FAC)] could not be defined; (iv) studies in which the outcome of comparison of both cannulation techniques was not reported or it was not possible to calculate this from the published results; (v) articles in languages other than English, and no-full-text. When multiple publications on the same patient sample were identified or study populations overlapped, only the latest report was included unless the reported outcomes were mutually exclusive. A consensus was reached if discrepancies were observed.
Data extraction
The identified studies for this meta-analysis were independently assessed by two investigators (Rui Hu and Zhen Zhou) for the study design: first author and year of publication, design of study, ethnicity of the study population, number of cases and controls; for the patient sample: patient gender, mean age, proportion of emergent surgery, preoperative comorbidities and follow-up years. The intraoperative data included surgical procedure, CPB time, aortic cross-clamp time, total circulatory arrest time and cerebral perfusion time. Study end points assessed included outcomes of interest: mortality (short-term or actual 30-day mortality), neurological dysfunction (permanent stroke and transient ischaemic attacks) and malperfusion (cerebral, visceral and lower extremity).
The study was performed in line with the recommendations of the proposal for reporting meta-analysis of observational studies in epidemiology [10] . The quality of the non-randomized studies was assessed by using a modified Newcastle-Ottawa Scale [11, 12] . The quality of the studies was evaluated by examining three items: patient selection, comparability of AXC and FAC groups, and assessment of outcomes. Table 1 gives this. For the comparability between the two groups, we focused on the following variables: age, sex, surgical technique and procedures, emergent/urgent No differences between the two groups, or differences controlled for, in particular with reference to variables a 1, 2, 3, 4 and 5 (two stars); one star was assigned if one of these five variables was not described even if there were no other differences between these two groups; no star was assigned if the two groups differed. 5. No differences between the two groups, or differences controlled for, in particular with reference to variables a 6, 7, 8 and 9 (two stars); one star was assigned if one of these four variables was not described even if there were no other differences between these two groups; no star was assigned if the two groups differed. Outcome assessment 6. Was the outcome of interest clearly defined? (if yes, one star was assigned if this information was investigated by record or interview; no star was assigned if this information was not identified). 7. Adequacy of follow-up (one star if no patient or fewer than 10% of patients were lost to follow-up).
AXC: axillary artery cannulation; FAC: femoral artery cannulation; AAD: type A aortic dissection; COPD: chronic obstructive pulmonary disease; CAD: coronary artery disease. *All nine studies were graded on an ordinal star scoring scale; more stars gained indicated higher quality. (0-5 stars = Level 1; 6-9 stars = Level 2). a Comparability variables: 1, age; 2, sex; 3, surgical technique and procedures; 4, emergent/urgent surgery; 5, hypertension; 6, neurological deficit/events; 7, CAD; 8, malperfusion (cerebral, visceral and lower extremity); 9, COPD. surgery, hypertension, neurological deficit/events, CAD, malperfusion (cerebral, visceral and lower extremity) and chronic obstructive pulmonary disease. If discrepant results were obtained, the articles were re-analysed by the two reviewers and a consensus was reached.
Statistical analyses
ORs and their 95% confidence intervals (CIs) were used to assess the difference between the two groups. Heterogeneity among studies was estimated using the χ 2 test and the Cochran Q score (reported as I 2 and representing the percent value of the heterogeneity). Heterogeneity was considered not significant if I 2 was <50%, and the fixed-effect model was used; otherwise, the random effect model was used.
We first assessed possible sources of heterogeneity within selected studies. The sensitivity of the meta-analysis was assessed after removal of studies in which the largest effect was found and of the study with the largest number of patients to find if our result was stable. Funnel plots were used to evaluate a publication bias, and the identified extreme studies were excluded to increase the robustness of our analyses.
We used the Cochrane Collaboration meta-analysis software, Review Manager 5.2, to perform data analysis, and the publication bias assessment was conducted using the RGui software. Data were presented as mean ± SD; a P-value of 0.05 for any test or model was considered to be statistically significant.
RESULTS
The literature search yielded 824 publications. After a review of the abstracts, a total of 43 articles were eventually deemed relevant. Of these 43 articles, 34 publications were excluded in the subsequent evaluation based on the inclusion/exclusion criteria; nine studies were eligible for the present meta-analysis: 359 patients in the AXC group and 356 patients in the FAC group [9, [13] [14] [15] [16] [17] [18] [19] [20] . No random clinical trial was included; eight were retrospective studies and one was a prospective study. Figure 1 shows the process for selecting final studies. The main characteristics of included studies are listed in Table 2 . The intraoperative data are listed in Table 3 . The outcomes of interest are listed in Table 4 .
On review of the data, extraction agreement between the two reviewers was 100%. Six of the nine studies were ranked at Level 1 and the remaining studies were classified as Level 2. Table 5 gives further details of the assessment of the quality of these studies.
Mortality
The postoperative short-term mortality was reported in nine studies [9, [13] [14] [15] [16] [17] [18] [19] [20] , and meta-analysis of the data showed that the Fig. 2A , differences of mortality reach statistical significance [odds ratio, 0.25, 95% CI (0.15, 0.42), χ 2 = 7.23, P < 0.01]. The test for heterogeneity was not statistically significant (I 2 = 0; P = 0.51), which indicates that the pooling of the data was valid.
Neurological dysfunction
Eight studies reported the neurological dysfunction in patients [9, 13-17, 19, 20] ; meta-analysis of the resultant data showed that the pooled neurological dysfunction in the AXC group was 14.3% (44/307) when compared with 26.4% (92/349) in the FAC group, and differences of neurological dysfunction reach statistical significance [odds ratio, 0.46, 95% CI (0.29, 0.72), χ 2 = 9.01, P < 0.01], as shown in Fig. 2B . The test for heterogeneity was not statistically significant (I 2 = 22; P = 0.25), which indicates that the pooling of the data was valid.
Malperfusion
Differences of malperfusion were extracted from six studies [9, 13, 14, [16] [17] [18] , and meta-analysis of these data showed that the pooled postoperative malperfusion in the AXC group was 5.7% (17/296) compared with 6.6% (14/213) in the FAC group, but did not reach statistical significance [odds ratio, 0.84, 95% CI (0.37, 1.90), χ 2 = 2.25, P = 0.67], as shown in Fig. 2C . The test for heterogeneity was not statistically significant (I 2 = 0; P = 0.81), which indicates that the pooling of the data was valid.
Sensitivity and publication bias analysis
We excluded studies with large ORs or a largest number of patients. Except for the decreasing I 2 value, most pooled estimates were similar and did not change materially. Funnel plots were used to assess the publication bias. Figure 3 shows the funnel plot for short-term mortality, neurological dysfunction and malperfusion. For mortality and neurological dysfunction, the plot appeared symmetrical, which indicates that publication bias of studies did not occur. For malperfusion, however, there seems to be a paucity of studies reporting a low rate of malperfusion in the AXC group, indicating some publication bias.
DISCUSSION
Although FAC has been used for CPB since the 1950s and the FA has been the primary site for peripheral arterial cannulation in repair for AAD [1, 21, 22] , AXC is gaining more and more attention, especially with its advantages in ACP, cerebral protection without any additional cannulation of brachiocephalic arteries and use of moderate hypothermia instead of deep hypothermic circulation arrest [8, 23, 24] . However, AXC requires a more precise technique and is more time consuming than FAC. Furthermore, technical problems and complications of AXC, such as axillary artery injury, brachial plexus injury, low CPB flow, arm ischaemia and malperfusion (required to be switched to FAC), are becoming well known with increased use. Thus, use of AXC versus FAC to perform cannulation in acute AAD has been the subject of a debate among surgeons.
Because treatment decisions must be based on available evidence and AXC has not been a routine cannulation site in most institutions, we performed this meta-analysis comparing surgical outcomes of AXC versus FAC within their own institution. No randomized data is available comparing AXC and FAC performance, and in non-randomized comparison, patient-and institutionrelated factors make meta-analysis difficult. So an appropriate study selection is important; only nine studies were judged eligible for our analysis. While the use of strict criteria reduced the total information, we believe this strategy enhanced the most valued outcomes' comparability for this analysis.
The meta-analysis presented sought to assess the current evidence for AXC or FAC in acute AAD repair. A total of 715 patients undergoing AXC or FAC retrieved from nine studies were included in the final meta-analysis. This meta-analysis identified that patients are more likely to benefit from AXC in acute AAD repair, as the reduction in the incidence of death and neurological dysfunction was more prominent. In spite of this, we believe that our findings suggest an essential relationship between artery cannulation and incidence of postoperative short-term mortality and neurological dysfunction in AAD repair. As Fig. 2 shows, the maximum OR favouring the AXC group was 0.42 (within 95% CI) for mortality and 0.72 for neurological dysfunction, meaning a relative risk reduction of at least 58 and 28%, respectively. For the studies included in our analysis, the average incidence rates of death and neurological dysfunction in patients undergoing FAC were 21.6 and 26.4%, respectively. Therefore, a 69.0% reduction in mortality would translate to an incidence rate of death with AXC of 6.7%, whereas a 45.8% reduction in neurological dysfunction would translate to an incidence rate of death with AXC of 14.3%. Several reviews have compared outcomes after AXC and FAC. Gulbins et al. [25] showed that AXC was associated with superior early outcomes in the parameters of mortality and neurological dysfunction. Tiwari et al. [26] showed that only 5 of 14 papers were found to report in favour of AXC over FAC. The discrepancies between papers may have several reasons: first, the different number and design of studies included; second, the patients included in the studies most likely had lower operative risks, taking into account the enrolment criteria of the studies; thirdly, we need to keep in mind that some operators may not use AXC regularly and would not have completed the learning curve. We must not ignore the benefits of AXC in AAD repair, as most of the studies look at FAC. Our meta-analysis is the first to show a significant decrease in short-term mortality and neurological dysfunction among patients undergoing AAD repair, who may indeed be the true beneficiaries of AXC.
Our meta-analysis suggests that AXC may be associated with a reduced risk of neurological dysfunction in the patients undergoing acute AAD repair. Studies comparing AXC and FAC report improved outcome, especially for neurological damage [9, 13, 14, 27] . Their results show a clear trend towards fewer neurological events in the AXC group. This trend seems to be attributed to ACP, which avoids complete circulatory arrest or reduces it to a minimal time frame. With ACP using the axillary artery (AXA), aortic arch repair can be done under moderate hypothermia during circulatory arrest of the body under perfusion [28] [29] [30] . Because the safety of deep hypothermic circulatory arrest does not have a true cut-off point, the results of the procedure are not always predictable. In addition, deep hypothermia has a strong influence on all organ systems, because all organ functions of the human body are optimized at 36.9°C. Therefore, deep hypothermia is a most invasive technique affecting functions of the whole body. Another source of neurological damage in aortic dissection repair is emboli originating from the diseased aorta. When FAC is used, a reversed flow direction results through the descending aorta that would be more likely to cause embolization of atherosclerotic plaque material into the supra-aortic vessels and result in brain damage or stroke.
In addition, we observed no difference in the incidence of malperfusion between the AXC and FAC groups. Tiwari et al. [26] reported that AXC can decrease the malperfusion rate based on a systematic review of 14 papers. However, this result must be interpreted cautiously, as selection of the cannulation route, either AXA or FA, affects both; this issue has been discussed [9, 16, 17] . Moreover, among these six studies which reported postoperative malperfusion, two studies reported both pre-and postoperative malperfusion. We must consider this point as potential heterogeneity. Accordingly, further well-designed randomized controlled trials on this topic are still needed to confirm our analysis.
Limitations of the study
The present study has some limitations that should be considered. First, heterogeneity and confounding factors may have distorted the analysis, because the two groups were not comparable for all the factors (especially study design, comorbidities and surgical procedures data) that can alter the outcomes of interest. Publication bias may also have affected the analysis, since studies that produced negative results may not have been published or may have been missed. In addition, our study is wholly based on studies published in English-language journals; studies in other language were not included. Also, the design of the study may lack random controlled trials. Meta-analysis is most effective when randomized studies are analysed. However, in this case this was not possible, as only observational studies have been performed, and in non-randomized comparison patient-and institution-related factors make analysis and comparison difficult and hazardous. A selection bias can be related to the fact that more experienced surgeons now consider AXC the standard of care in the management of acute AAD and may object to their patients being randomized to receive FAC in a single centre. Nonetheless, in the absence of well-controlled randomized studies, this is a suggested approach to search for the 'best evidence' [31] . Although it has been stated that meta-analysis of non-randomized studies presents methodological difficulties and the results are not reliable [32] , we suggest that some numerical information is better than none.
Conclusion
Our study suggests that AXC may reduce the short-term mortality and neurological dysfunction in patients undergoing acute AAD repair. The superior results of AXC seem to be attributed to the ACP through the whole procedure and avoidance of circulatory arrest, which reduced the neurological dysfunction rate. Nevertheless, the cannulation strategy for AAD should be chosen on the basis of the patient's characteristics. The lack of high-quality randomized prospective and multicentre trials does not allow a general recommendation of AXC as the new routine cannulation site of choice in patients with acute AAD repair.
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